Kinder- und Jugendrheumatologe
zugelassen durch die Ärztekammer Hamburg;
Ärztekammer-Zugehörigkeit: Ärztekammer Hamburg (siehe gültige Berufsordnung)
Zertifizierte Fortbildungspunkte von der Ärztekammer Hamburg: 2009: 147 Punkte 2004-2008: 953 Punkte 2007-2011: 941 Punkte
Bisherige wissenschaftliche Veröffentlichungen.
Akademische Ausbildung
| 1979 | Medizinstudium an der J.W.Goethe-Universität, Frankfurt/Main |
| 1980 | Medizinstudium an der Semmelweiss-Universität, Budapest, Ungarn |
| 1986 | Staatsexamen und Promotion mit „summa cum laude“ an der Semmelweiss-Universität, Budapest Doktorarbeit: „Immunmodulationstherapie“ Doktorvater: P. Gergely, I. Medizinische Klinik, Semmelweiss Universität, Budapest |
| 1989-1990 | Ausbildung in Kinderrheumatologie (fellowship) unter der Leitung von J. C. Jacobs, Columbia University, New York, N. Y., USA |
| 1995 | Abschluss der Ausbildung in Kinderrheumatologie (fellowship) am Children’s Hospital of the University of British Columbia, Vancouver, Kanada, unter der Leitung von Prof. Dr. R.E. Petty |
| 1996 | Abschluss der Ausbildung in Kinderheilkunde |
Zertifikation
| 1988 | ECFMG Certifikation |
| 1991 | TOEFL |
| 1991 | TSE |
| 1993 | FLEX parts I +II (Federal Lisencing Exam, USA) |
| 1996 | Facharzt für Kinderheilkunde |
| 2005 | Erhalt der Zusatzbezeichnung „Kinder-Rheumatologe“ |
| 2016 | GCP Kurs update |
| 2019 | GCP Kurs |
| 2022 | GCP Kurs |
Ärztliche Tätigkeit
| 1986-1987 | Assistenzarzt an der II. Medizinischen Klinik der Universität für Ärztliche Fortbildung, Budapest |
| 1988-1989 | Assistenzarzt am Clementinen-Kinderkrankenhaus, Frankfurt/Main |
| 1989-1990 | Ausbildung in Kinderrheumatologie (fellowship) unter der Leitung von J. C. Jacobs, Columbia University, New York, N. Y., USA |
| 1990-1993 | Wissenschaftlicher Mitarbeiter an der Universitätskinderklinik, Hamburg |
| 1993-1995 | Kinderrheumatologische Ausbildung „Clinical and Research Fellow“ am Children’s Hospital, University of British Columbia, Vancouver, Kanada (DAAD-Stipendiat) |
| 1995-2000 | Wissenschaftlicher Mitarbeiter an der Universitätskinderklinik, Hamburg |
| 12/1996 | Betreuung der kinderrheumatologischen Sprechstunde an der Universitätsklinik Hamburg |
| 12/1997 | Ernennung zum Beamten auf Zeit (C1-Stelle) |
| 08/1998 | persönliche Ermächtigung zur Versorgung rheumakranker Kinder und Jugendlicher |
| 09/2000 | selbständige Tätigkeit als niedergelassener Kinder- und Jugendrheumatologe (Sonderbedarfszulassung für Hamburg) |
| 01/2007 | Leiter des Zentrums Hamburger Zentrums für Kinder- und Jugendrheumatologie am Klinikum Eilbek |
| 08/2007 | Etablierung und Leitung des Kompetenz-Zentrums für Sklerodermie im Kindes- und Jugendalter, am Klinikum Eilbek |
| 05/2009 | Etablierung und Leitung des Kompetenz-Zentrums für Uveitis im Kindes- und Jugendalter, am Klinikum Eilbek |
Lehrtätigkeit
| 1990-1993 | Teilnahme am Studentenunterricht als Assistenzarzt – bed-side-teaching |
| 1993-1995 | Unterrricht der Assistenzärzte im Rahmen des fellowships für Kinder und Jugendrheumatologie |
| 1995-2000 | Teilnahme am Studentenunterricht als Assistenzarzt – bed-side-teaching |
| 2003/2004 | Wintersemester – Dozent für bed-side-teaching an der Universitätskinderklinik in Hamburg |
| 2009- | Kinderklinik Budapest |
| 2010- | Semmelweis Universität, Asklepios Campus in Hamburg, für Kinder- und Jugendrheumatologie |
Fakultät
| 2010- | Dozent an der Semmelweis Universität Asklepius Campus in Hamburg für Kinder- und Jugendrheumatologie |
| 2011- | Fakultät an der EULAR/EUSTAR Sklerodermie Kurs in Belgrad |
| 2013- | Fakultät an der EULAR/EUSTAR Sklerodermie Kurs in Cluj |
| 2022- | EULAR/EUSTAR Sklerodermie- Kurs Riccione, Italien |
| 2022- | Consultant for the European Reference Network RITA |
Mitgliedschaften und Auszeichnungen
| 1979 | Empfehlung der Studienstiftung des Deutschen Volkes für das Hochschulstudium |
| 1990 | Mitglied als „Trainee“ des American College of Rheumatology, Section on Pediatric Rheumatology |
| 1991 | Gründungsmitglied der Deutschen Kinderrheumatologischen Gesellschaft |
| 1991 | „Affiliate Member“ der American Academy of Pediatrics |
| 1999 | Mitglied des “International Systemic Sclerosis Trials Consortium” |
| 2000 | Leiter der “Scleroderma Working Group of the European Pediaric Rheumatologic Society” |
| 2001 | Mitglied des “Steering Committee for the International Juvenile Scleroderma Working Group” |
| 2001 | Mitglied des „Executive Committee for 1st European Network meeting for Juvenile Dermatomyositis“ |
| 2001 | Secretary of the „Scleroderma Working Group of the European Pediatric Rheumatologic Society“ |
| 2001 | Stellvertretender Leiter der Arbeitsgruppe Qualitätsicherung der Deutschen Gesellschaft für Kinder- und Jugendrheumatologie |
| 2003 | Mitglied Deutsche Gesellschaft für Rheumatologie e.V. |
| 2005 | Mitglied des Berufsverbandes Deutscher Rheumatologen e.V. |
| 2007 | British Society of Rheumatology |
| 2009 | Begründer und Leiter der Juvenile Uveitis Outcome Measure Group |
| 2009 | Leiter der PRES Skleroderma Working Group |
| 2009 | Mitglied der Connective Tissue Disease Related Interstitial Lung Disease Special Interest Group |
| 2009 | Mitglied der Flare Group of the OMERACT (Outcome Measures in Rheumatology) |
| 2010 | Leiter der EUSTAR (European Leag against Rheumatism Scleroderma Trial and Research Group) – Arbeitsgruppe für Sklerodermie im Kindesalter |
| 2010 | Mitglied von EBMT auf Einladung |
| 2010 | Mitglied von der OMERACT Connective Tissue Disease Interstitial Lung Disease Special Interest Group |
| 2011 | Fachbeisitzer und Prüfer der im Weiterbilungs-/ Prüfungsausschuss durch die Delegiertenversammlung der Ärztekammer Hamburg |
| 2011 | Leiter der Uveitis Arbeitsgruppe der Pediatric Rheumatology European Society |
| 2013 | Mitglied der WG6 Enpr-EMA ad-hoc working groups (A framework for networks to interact with industry and regulators when implementation/conduct of clinical trials agreed in PIPs is no longer possible of the European Network of Paediatric Research at the EMA) |
| 2014 | Mitglied der EULAR – study group- Microcirculation in Rheumatoid Diseases- by invitation |
| 2014 | Mitglied – European Network for Localised Scleroderma – by invitation |
| 2014 | Mitglied – der EULAR /EUSTAR Gruppe- Treatment Guidelines for Systemic Sclerosis |
| 2015 | Mitglied – der European Dermatology Forum- Konsensus Meeting for Sclerosing Diseases |
| 2015/2016 | Member of the scientific organising commite for the PRES annual meeting 2016 |
| 2017 | Working group on capillaroscopy, EULAR |
| 2017 | Founding member of the juvenile Scleroderma working group on the Scleroderma Clinical Trial Consortium (SCTC) |
| 2017 | Member of the Activity Working group of the SCTC |
| 2018 | Founder of the Pediatric Working group of the SCTC |
| 2019- | Working group leader of the PRES Scleroderma working group |
| 2019 | Clinical chair of the PRES Uveitis working group |
| 2019- | Member of the ENPRA working group “labelling info based on treatment practice” |
| 2020 | Member of the scientific organizing committee for the PRES annual meeting 2020 |
| 2021 | Member of the scientific organising commite for the PRES annual meeting 2021 |
| 2022- | Guest consultant in der European Reference Network for Pediatric Rheumatology by invitation |
| 2022- | American College of Rheumatology Annual Meeting Abstract Reviewing Cochair |
| 2023 | Member of the ENPRA working group – site quality |
Stipendien
| 1989-1990 | Ausbildungsstipendium der Deutschen Forschungsgemeinschaft, im Bereich Kinderrheumatologie bei Prof. J.C. Jacobs an der Columbia University, New York, N.Y., USA |
| 1993-1995 | Forschungs- und Weiterbildungsstipendium des DAAD im Rahmen der Kinderrheumatologieweiterbildung bei Prof R.E. Petty, University of British Columbia, Vancouver, Kanada |
Spezialkurse
| 1994 | Kurs Klinische Epidemiologie (veranstaltet vom „Department of Health Care and Epidemiology of the University of British Columbia“, Vancouver) |
| 1996 | Intensive epidemiology course for the rheumatologists , 26.2- 1.3.1996, Manchester, UK, (veranstaltet vom „The Arthritis and Rheumatism Council Epidemiology Research Unit“) |
| 1998 | Measurement in health care 9.-11.3 1998 am Potsdam Institute of Pharmacoepidemiology, geleitet von Prof. Sharon Wood-Dauphinee, Department of Epidemiology and Biostatistics School of Physical and Occupational Therapy, McGill University, Montreal, Kanada |
| 1998 | Epidemiology:Principles and Methods* 5.-10.10.1998 am Potsdam Institute of Pharmacoepidemiology, geleitet von Prof.J.F.Boivin, Department of Epidemiology and Biostatistics, McGill University, Montreal, Kanada. (* Teil einer Ausbildung zum „Master“ in Clinical Epidemiology) |
| 1999 | Medizinische und gesundheitsökonomische Entscheidungsanalyse 29.-30.1.1999 an der Universität Hamburg |
| 2000 | Klinische Studien und Krankenhausalltag. So bringt man beides zusammen. 17.-18.11.2000, Berlin, veranstaltet von Institut für klinisch-kardiovaskuläre Forschung |
| 2008 | Grundlagen zur klinischen Prüfung von Arzneimitteln nach AMG und ICH-GCP |
| 2016 | Health Economic Course, Nancy organised by EULAR |
| 2019 | GCP Aufbaukurs |
| 2022 | GCP Kurs |
Editor
| 2002-2008 | Medactuell Rheumatologie (Review Journal), Sektion Kinder- und Jugendrheumatologie |
| 2009 | Clinical Experimental Rheumatology – Systemic Scleroderma journal editorial board |
| 2010 | Pediatric Rheumatology Online Journal |
| 2014 | Scleroderma Society, UK- Publication board |
| 2014 | Annals of Pediatric Rheumatology |
| 2015 | Journal of Scleroderma and Related Disorders |
| 2020 | Review Editor for Frontiers in Pediatrics |
| 2022 | Arthritis Care and Research |
Advisor
| 2005 | Advisory Board für Infliximab / Essex Pharm |
| 2006 | Mitglied der Medical Scientific Commitee- Scleroderma Society (www.sclerodermasociety.co.uk) |
| 2007 | International Advisory Board Encysive |
| 2008 | International Advisory Board Roche Pharma |
| 2008 | International Advisory Board BMS |
| 2008 | International Advisory Board BMS |
| 2009 | Nationale Advisory Board Abbott, Wyeth |
| 2009 | Advisor on the European Medicine Agency (EMEA), London, UK – Pediatric Rheumatology Board |
| 2010 | National Advisory Board- Abbot,BMS, Chugai |
| 2010 | Advisor on the European Medicine Agency (EMEA), London,UK – Pediatric Rheumatology Board |
| 2011 | National Advisory Board- Abbot, Chugai, Novartis |
| 2012 | National Advisory Board- Abbott, Chugai |
| 2013 | National Advisory Board- Abbott |
| 2014 | Uveitis Advisory Board Pfizer |
| 2014 | National Advisory Board JIA Chugai |
| 2015/ 201/ | National Advisory Board Novartis |
| 2016 | Bayer – regarding juvenile scleroderma studies |
| 2016 | Genentech- regarding juvenile scleroderma studies |
| 2017 | National Advisory Board Novartis |
| 2017 | National Advisory Board Chugai |
| 2017 | Advisory Board for JIA associated Uveitis Abbvie |
| 2017 | International Advisory Board for JIA associated Uveitis Abbvie |
| 2017 | International Advisory Board JIA Lilly Pharmaceuticals |
| 2018 | International Advisory Board JIA Lilly Pharmaceuticals |
| 2018 | National Advisory Board for Novartis |
| 2018 | National Advisory Board for BMS |
| 2018 | Regional Advisory Board Pfizer |
| 2018 | International Advisory Board Lilly |
| 2019 | National Advisory Board GSK |
| 2019 | National Advisory Board for BMS |
| 2019 | National Advisory Board Sanofi |
| 2019 | Regional Advisory Board Pfizer |
| 2019 | National Advisory Board Abbvie – Uveitis |
| 2019 | National Advisor MEDAC |
| 2020 | Regional Advisory Board for Gilead |
| 2020 | National Advisory Board Novartis |
| 2020 | Advisor for Pfizer Germany – Thought for Future |
| 2020 | Advisor for Hexal Germany – Patient information booklet |
| 2020 | Advisor for Thermo Fischer |
| 2021 | Advisor for Hexal- Transition issues |
| 2021 | Advisor for Novartis Autoinflammation |
| 2021 | International advisory board for Lilly |
| 2021 | International advisory board for Novartis Secukinumab |
| 2021 | National advisory board for Novartis Secukinumab |
| 2021 | Advisor for Medac Germany – Patient information booklet |
| 2022 | Advisor for HEXAL |
| 2022 | Advisor MEDAC |
| 2023 | Advisor Lilly |
| 2024 | Advisor Mitsubishi |
| 2024 | Advisor Boehringer Ingelheim |
Rezensent
| 1996 | Pediatrics |
| 1998 | Scandinavian Journal of Rheumatology |
| 2001 | The Journal of Rheumatologyy |
| 2002 | European Journal of Pediatrics |
| 2002 | Expert Opinion on Pharmacotherapy |
| 2003 | European Journal of Pediatrics |
| 2003 | Pediatric Rheumatology Online Journal |
| 2003 | Pediatric Drugs |
| 2003 | Journal of Rheumatology |
| 2003 | The Italian Journal of Pediatrics |
| 2003 | Zeitschrift für Rheumatologie |
| 2003 | Annals of Rheumatic Diseases |
| 2004 | Annals of Rheumatic Diseases |
| 2004 | Zeitschrift für Rheumatologie |
| 2004 | 2004 Clinical and Experimental Rheumatology |
| 2004 | Clinical Drug Investigation |
| 2004 | J Rheumatol |
| 2005 | The Journal of Rheumatology |
| 2005 | Pediatric Rheumatology online Journal |
| 2005 | Drugs Evaluation |
| 2005 | Rheumatology |
| 2006 | Arthritis Research & Therapy |
| 2006 | Arthritis and Rheumatism |
| 2006 | The Journal of Rheumatology |
| 2007 | Arthritis and Rheumatism |
| 2007 | Rheumatology |
| 2007 | Journal for Rheumatology |
| 2007 | British Journal of Dermatology |
| 2008 | Journal of Rheumatology |
| 2008 | Arthritis Therapy and Research |
| 2008 | Rheumatology |
| 2008 | British Journal of Dermatology |
| 2008 | Annual Meeting of the American College of Rheumatology – Abstract Selection commitee |
| 2008 | Jahreskongress der Detuschen Gesellschaft für Rheumatologie – Abstract Selektions Komitee |
| 2008 | Pediatrics International |
| 2009 | Rheumatology |
| 2009 | Pediatric drugs |
| 2009 | Arthritis and Rheumatism |
| 2009 | Jahreskongress der Deutschen Gesellschaft für Rheumatologie- Abstract Selektions Komitee |
| 2009 | Journal of Rheumatology |
| 2009 | Sultan Qaboos University Medical Journal |
| 2009 | Clinical and Experimental Rheumatology |
| 2009 | Advances in Pharmacological Sciences |
| 2009 | Arthritis Care & Research |
| 2010 | Arthritis and Rheumatism |
| 2010 | Pediatric Rheumatology online Journal |
| 2010 | International Journal of Clinical Rheumatology |
| 2010 | Rheumatology |
| 2010 | Clinical and Experimental Rheumatology |
| 2010 | Rheumatology International |
| 2010 | Journal of Rheumatology |
| 2010 | Arthrtitis Care & Research |
| 2010 | Zeitschrift für Rheumatologie |
| 2010 | British Journal of Dermatology |
| 2010 | Ann Rheum Diseases |
| 2010 | Seminars in Arthritis and Rheumatism |
| 2010 | Klinische Pädiatrie |
| 2010 | Lancet |
| 2010 | Rheumatology International |
| 2011 | Rheumatology |
| 2011 | Clinical Experimantel Rheumatology |
| 2011 | International Journal of Rheumatic Diseases |
| 2011 | British Journal of Dermatology |
| 2011 | Arthritis Care and Therapy |
| 2011 | Pediatric Rheumatology online Journal |
| 2011 | Nature Review Rheumatology |
| 2011 | Zeitschrift für Rheumatologie |
| 2011 | Pulmonary Medicine |
| 2012 | Clinical and Experimental Rheumatology |
| 2012 | Rheumatology |
| 2012 | Annals of Rheumatic Diseases |
| 2012 | Pediatric Rheumatology online Journal |
| 2012 | Arthritis Research & Therapy |
| 2012 | Zeitschrift für Rheumatologie |
| 2012 | Expert Review of Gastroenterology & Hepatology |
| 2013 | Ped Rheum on line Journal |
| 2013 | Arthritis Care and Research |
| 2013 | Rheumatology |
| 2013 | Clinical Experimental Rheumatology |
| 2013 | Journal of Rheumatology |
| 2013 | Mediators of Inflammation |
| 2013 | International Journal of Rheumatic Diseases |
| 2013 | Annals of Rheumatic Diseases |
| 2014 | Annals of Rheumatic Diseases |
| 2014 | Expert Review of Clinical Immunology |
| 2014 | Arthritis Care and Research |
| 2014 | Future in Medicine |
| 2014 | Journal of Rheumatology |
| 2014 | Nature Reviews in Rheumatology |
| 2014 | Zeitschrift für Rheumatologie |
| 2014 | Clinical and Experimantel Rheumatology |
| 2014 | Survey of Ophthalmology |
| 2014 | Pediatric Drugs |
| 2014 | Rheumatology International |
| 2014 | Seminars in Arthritis and Rheumatism |
| 2015 | Arthritis Care and Therapy |
| 2015 | Pediatric Rheumatology Online Journal |
| 2015 | Clinical Rheumatology |
| 2015 | Arthritis Care and Research |
| 2015 | Rheumatology |
| 2015 | Annals of Pediatric Rheumatology |
| 2015 | Pediatric Drugs |
| 2015 | Clinical and Experimantel Rheumatology |
| 2015 | Expert Review of Clinical Immunology |
| 2015 | Zeitschrift für Rheumatologie |
| 2015 | Annals of Rheumatic diseases |
| 2015 | Expert Opinion on Pharmacotherapy |
| 2015 | Journal of Dermatology Research and Therapy |
| 2015 | Archivum Immunologiae et Therapiae Experimentalis |
| 2015 | Archives of Dermatological Research |
| 2016 | Journal of Rheumatology |
| 2016 | Zeitschrift für Rheumatologie |
| 2016 | Pediatric Rheumatology |
| 2016 | Clinical Experimantal Rheumatology |
| 2016 | Arthritis Care and Therapy |
| 2016 | Expert Review of Ophthalmology |
| 2016 | Expert Opinion of Pharmacotherapy |
| 2016 | Current Pharmaceutical Design |
| 2017 | Clinical Experimantal Rheumatology |
| 2017 | Journal of Scleroderma and related disorders |
| 2017 | Bosnian Journal of Basic Medical Sciences |
| 2017 | Grant review- UK Scleroderma and Raynauds Foundation |
| 2017 | International Journal of Rheumatic Diseases |
| 2017 | Swiss Medical Weekly |
| 2017 | Annals of Rheumatic Diseases |
| 2017 | Arthritis Care and Therapy |
| 2017 | Rheumatology |
| 2017 | Pediatric Rheumatology online Journal |
| 2017 | Acta Dermato-Venerologica |
| 2017 | Seminars in Arthritis and Rheumatism |
| 2018 | Annals of Rheumatic Disease |
| 2018 | Journal of Scleroderma and related disorders |
| 2018 | Pediatric Rheumatology |
| 2018 | Seminars in Arthritis and Rheumatism |
| 2018 | Clinical, Cosmetic and Investigational Dermatology |
| 2018 | Immunotherapy |
| 2018 | Arthritis Research & Therapy |
| 2018 | Arthritis Care & Research |
| 2018 | Journal of Rheumatology |
| 2018 | Ocular Immunology and Inflammation |
| 2018 | Pediatric Rheumatology online Journal |
| 2019 | Ocular Immunology and Inflammation |
| 2019 | Arthritis Care and Research |
| 2019 | Zeitschrift für Rheumatologie |
| 2019 | Arthritis Research & Therapy |
| 2019 | Journal of Rheumatology |
| 2019 | Expert Opinion on Drug Delivery |
| 2019 | Pediatric Rheumatology online journal |
| 2019 | Jornal de Pediatria |
| 2019 | Journal of Scleroderma and Related Disorders |
| 2019 | Reviews in Cardiovascular Medicine |
| 2020 | Seminars in Arthritis and Rheumatism |
| 2020 | Journal of Scleroderma and Related Disorders |
| 2020 | Journal of Clinical Medicine |
| 2020 | Uveitis Guideline of the American Academy of Pediatrics |
| 2020 | Arthritis Care and Therapy |
| 2020 | Expert Opinion on Pharmacotherapy |
| 2020 | Arthritis Care and Research |
| 2020 | Clinical, Cosmetic and Investigational Dermatology |
| 2020 | Pediatric Rheumatology |
| 2020 | Clinical Experimental Rheumatology |
| 2020 | Seminars in Arthritis and Rheumatism |
| 2020 | Arthritis Research & Therapy |
| 2020 | Journal of Rheumatology |
| 2020 | Unicorn |
| 2021 | Clinical Opthalmology |
| 2021 | ACR Open Rheumatology |
| 2021 | Expert Review of Clinical Immunology |
| 2021 | Frontiers |
| 2021 | Lancet Rheumatology |
| 2021 | Journal of Biomedical Research and Reviews |
| 2021 | Arthritis Research & Therapy |
| 2021 | Clinical Medicine Insights: Arthritis and Musculoskeletal Disorders |
| 2021 | Frontiers in Pediatrics |
| 2021 | Pediatric Rheumatology |
| 2021 | Nature Reviews Disease Primers |
| 2021 | Journal of Pediatria |
| 2021 | Pain Medicine |
| 2022 | Frontiers in Pediatrics |
| 2022 | Expert Review of Clinical Immunology |
| 2022 | Clinical, Cosmetic and Investigational Dermatology |
| 2022 | Journal of Scleroderma and related Disorders |
| 2022 | British Journal of Dermatology |
| 2022 | Arthritis Care and Therapy |
| 2022 | Journal of Rheumatology |
| 2022 | Pediatric Rheumatology online journal |
| 2022 | Journal of Inflammation Research |
| 2022 | Seminars in Arthritis and Rheumatism |
| 2023 | Journal of Rheumatology |
| 2023 | Lancet Rheumatology |
| 2023 | Children |
| 2023 | Pediatric Rheumatology |
| 2023 | Arthritis Care and Therapy |
| 2023 | Longhua Chinese Medicine |
| 2023 | Springer Nature |
| 2023 | Arthritis Care and Research |
| 2023 | Pediatric Drugs |
| 2023 | Clinical, Cosmetic and Investigational Dermatology |
| 2023 | Expert Opinion On Biological Therapy |
| 2024 | Arthritis Care and Research |
| 2024 | Pediatric Rheumatology |
| 2024 | Clinical Medical Insights.Pediatrics |
| 2024 | Nature Reviews in Rheumatology |
| 2024 | BMJ Case Reports |
| 2024 | Journal of Scleroderma and Related disorders |
| 2024 | Seminars in Arthritis and Rheumatism |
| 2024 | Journal of Rheumatology |
| 2024 | Rheumatology |
Leitung internationaler wissenschaftlicher Projekte
| 2005 | Juvenile Systemic Scleroderma-Inceptionscohort www.juvenile-scleroderma.com |
| 2007 | Outcome measures for prospective clinical trials in juvenile idiopathic arthritis-associated uveitis: a consensus effort from the multinational interdisciplinary working group for uveitis in childhood (MIWGUC) |
| 2024 | Scientific Committee on the first 1st PReS ACADEMY COURSE on Non-Infectious Childhood Chronic Uveitis, Florence, Italy |
Teilnahme an und Leitung von internationalen Zulassungsstudien
| 1999 | Phase I/II Studie für Meloxicam |
| 2000 | Phase III Studie für Meloxicam |
| 2001 | Phase III Studie für Rofecoxib |
| 2002 | Phase III Studie für Leflunomid |
| 2002 | Phase III Studie für einen neuen TNF-alfa Blocker, Nationale Lead Investigator |
| 2003 | Phase III Studie für einen anderen neuen TNF-alfa Blocker, Nationale Lead Investigator |
| 2004 | Phase III Studie für einen neuen biologische Immunmodulator |
| 2004 | Phase III Studie für einen neuen COX-2 Hemmer, National Lead Investigator (LKP) |
| 2007 | Phase II Studie für einen neuen biologischen Immunmodulator |
| 2007 | Enbrel once weekly in Juvenile idiopathische polyartikuläre Arthritis |
| 2008 | Humira in juvenile idiopathische Enthesitis assoziierte Arthritis |
| 2009 | 2009 Canalimumab in CAPS – Phase III. study |
| 2009 | Canalimumab in sJIA- Phase III. study |
| 2009 | Etanercept in oJIA , enthesitis related JIA and psoriatic JIA Phase III. study |
| 2009 | US assessment of activity of localised scleroderma lesion- international study |
| 2010 | Adalimumab in poly Juveniler Idiopathischer Arthritis from 2 to 4 years of age |
| 2010 | Adalimumab – Phase IV in polyarticulare course JIA |
| 2010 | Canalimumab – Phase IV in CAPS |
| 2010 | Adalimumab – Phase III – in enthesitis related JIA |
| 2010 | Gololimumab – Phase III – in polyarticulare course JIA |
| 2013 | Tofacitinib – Phase II/ III – in polyarticular course Juveniler Idiopathischer Arthritis |
| 2015 | Canakinumab dose reduction study in systemic JIA |
| 2017 | Saralimumab Phase II study in poly JIA |
| 2017 | Saralimumab Phase III study s JIA |
| 2017 | Tofacitinib Phase III study sJIA |
| 2017 | Cosentyx Phase III study in enth JIA |
| 2018 | Sarolimumab Phase II study in sJIA |
| 2019 | Sarolimumab Phase III study in pJIA |
| 2019 | Baricitinib Phase III study in JIA |
| 2019 | Uptacitinib Phase II study in JIA |
| 2020 | Baricitinib Phase III study JIA associated Uveitis |
| 2020 | Belolimumab s.c. Phase III in SLE |
| 2020 | Aprelimast Phase III Studie in JIA |
| 2021 | Ixtekinumab Phase III Studie in JIA |
| 2021 | Aprelimast Phase III Studie in JIA |
| 2023 | Guselkinumab Phase III Studie in JIA |
Chairman
| 2000 | European Pediatric Rheumatology meeting |
| 2004 | EULAR- Pediatric Rheumatology Session |
| 2004 | ACR – Pediatric Scleroderma Symposium |
| 2006 | DGRH – Kinderrheumatologie-Postersession |
| 2007 | DGRH – Kinderrheumatologe Symposium |
| 2009 | DGRH – Kinderrheumatologie-Postersession |
| 2010 | PRES- Skleroderma Session |
| 2009 | DGRH – Kinderrheumatologie-Postersession |
| 2010 | DGRH – Der besonderer Fall |
| 2011 | PRES Meeting |
| 2011 | DGRH Meeting |
| 2013 | Controversies in Rheumatology & Autoimmunity (CORA), Budapest |
| 2013 | DGRH/GKJR Meeting |
| 2014 | Annual European Pediatric Rheumatology Meeting Belgrad |
| 2017 | European Postgraduate Course of Pediatric Rheumatology, Ljubjana, Slovenia – 17-19th of March |
| 2017 | Pediatric Rheumatology Congress 2017, Athens, Chairman of the Juvenile Scleroderma Session |
| 2021 | Member Abstract selection committee PRES 2021 |
| 2021 | Moderator on the Annual PRES Meeting |
| 2022 | Abstract Chair ACR Congress |
| 2022 | Member Abstract selection committee PRES 2022 |
| 2022 | Member Abstract selection committee ACR 2022 |
| 2023 | Member Abstract selection committee PRES 2023 |
| 2023 | Member Abstract selection committee ACR 2023 |
| 2024 | Member Abstract selection committee PRES 2024 |
| 2024 | Member Abstract selection committee ACR 2024 |
Preise
| 2009 | Posterpreis der DGRH 2009 |
Andere Aktivitäten
| 1998 | Grundungsinitiator des Hamburger Elternverein Rheumakranker Kinder e.V. |
| seit 1998 | regelmäßige lokale Fortbildungen für Augenärzte, Orthopäden, Kinderärzte, Rheumatologen und Kieferorthopäden |
| 2000 | Sekretär der PRESS ( European Pediatric Rheumatology Sociaty)- working-group for Juvenile Scleroderma |
| seit 2000 | Jährlicher Veranstalter des „Tages des Rheumakranken Kindes und Jugendlichen“ in Hamburg |
| seit 2000 | Veranstalter des jährlichen Fortbildungtages für Krankengymnasten und Ergotherapeuten über die Kinder- und Jugendrheumatologie |
| 2001 | Sekretär der PRESS (Pediatric Rheumatology European Society) – working-group for Juvenile Scleroderma |
| 2002 | Organisation der I. International workshop on juvenile Scleroderma Syndromes (Padua, Italien) |
| 2004 | Teilnehmer der II. International workshop on juvenile Scleroderma Syndromes (Padua, Italien) und Konsensus Konferenz für die Klassifikation der juvenilen Sklerodermie |
| 2004 | Leiter der Kinderrheumatologie Sektion des Deutschen Sklerodermie Netzwerkes |
| 2005 | Mitglied der OMERACT (Outcom Measures in Rheumatology – Systemic Scleroderma Working Group |
| 2006 | Mitglied der klinischen Forschungskomission von EUSTAR, Systemishe Sklerodermie Arbeitsgruppe von EULAR (European Leage against Rheumatism) |
| 2008 | Organisator des Jährlichen Internationalen Meetings in Hamburg „Hamburg Symposium on Juvenile Scleroderma – update on new developments” |
| 2012 | Leiter der juvenilen Sklerodermie des SHARE Projektes – EU- FP 7 Projekt |
| 2012 | Leiter der juvenilen Sklerodermie des Desscriptor Projektes – EU- FP 7 Projekt |
Fortbildungspunkte